04:05 PM EDT, 05/29/2025 (MT Newswires) -- PharmaCorp Rx (PCRX.V) Thursday reported it swung to a profit of $254,000 for its first quarter, an improvement over a loss of $202,469 a year earlier, and said it entered into four non-binding Letters of Intent to acquire four community pharmacies for approximately $12.5 million.

The company's sales were $4 million, up from nil, from its three pharmacies. Prescription volumes were higher, with total script count rising 3.2% year-over-year, demonstrating "sustained patient engagement and activity" across the network.

"This marks an important milestone for PharmaCorp as we deliver our first quarter of positive net income," said Chief Financial Officer Terri Tatchell. "Our results reflect a disciplined approach to cost management, steady growth in prescription volumes, and early returns from our operating model. We are confident this momentum will continue to build in the quarters ahead."

PharmaCorp shares closed down $0.005 to $0.46 on the TSX Venture Exchange.